UBS Reiterates Sell Rating on IBM (IBM) Following Confluent Deal Announcement

December 9, 2025 8:02 AM EST Send to a Friend
UBS analyst David Vogt reiterated a Sell rating and $210.00 price target on IBM (NYSE: IBM).The analyst commented, "Based on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login